HB
Heena Bhojwani
Scientimed Solutions, Alembic Pharmaceuticals Ltd, KM Kundnani College of Pharmacy
Research areas: Chemistry · Organic Chemistry · Computational Drug Discovery Methods · Synthesis and biological activity · Synthesis and Characterization of Heterocyclic Compounds
0000-0003-2589-6336
Employment
-
Scientimed Solutions Senior Medical Writer
-
Alembic Pharmaceuticals Ltd Manager Medical Writing and Publication
Education
-
KM Kundnani College of Pharmacy PhD2017 - 2023
Projects & Funding
Projects & funding information is unavailable.
Publications (16)
- Management of Hypertension and Associated Comorbidities: An Expert Consensus Statement from India. Save
- Optimizing the Diagnosis and Management of Nocturnal Hypertension: An Expert Consensus from India. Save
- Integrative computational approaches in pharmaceuticals: Driving innovation in discovery and delivery. Save
- Integrated pharmacophore‐based screening and docking strategy for identifying type II inhibitors of VEGFR‐2 kinase Save
- Oral Natural Micronized Progesterone: A Review of Its Implications in Obstetric Indications Save
- Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors Save
- Design, synthesis, and biological evaluation of 2, 4-dichlorophenoxyacetamide chalcone hybrids as potential c-Met kinase inhibitors Save
- Homology Modelling, Docking-based Virtual Screening, ADME Properties, and Molecular Dynamics Simulation for Identification of Probable Type II Inhibitors of AXL Kinase Save
- Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis, In-Vitro Inhibition, and Molecular Modeling Studies Save
- Cinnamamide-chalcone derivatives as CDK2 inhibitors: synthesis, pharmacological evaluation, and molecular modelling study Save
- Cinnamamide-Chalcone Derivatives as CDK2 Inhibitors: Synthesis, Pharmacological Evaluation, and Molecular Modelling Study Save
- Studies in molecular modeling, in-vitro CDK2 inhibition and antimetastatic activity of some synthetic flavones. Save
- [] Save
- Selection of Best Crystal Structure for Initiating Docking-Based Virtual Screening Studies of Cdk2 Inhibitors: A Cross-Docking and Dud Set Validation Approach Save
- Strategies to select the best pharmacophore model: a case study in pyrazoloquinazoline class of PLK-1 inhibitors Save
- Pharmacophore and docking guided virtual screening study for discovery of type I inhibitors of VEGFR-2 kinase Save